Literature DB >> 15846783

Nerve growth factor-mediated collateral sprouting of central sensory axons into deafferentated regions of the dorsal horn is enhanced in the absence of the p75 neurotrophin receptor.

Sari S Hannila1, Michael D Kawaja.   

Abstract

This study examined the growth capacity of nerve growth factor (NGF)-responsive dorsal root ganglion (DRG) central processes using mice of the following genotypes: wildtype, p75 neurotrophin receptor (p75NTR) exon III null mutant, NGF transgenic, and NGF transgenic with p75NTR exon III null mutation (NGF/p75(-/-)). In wildtype and p75NTR exon III null mutant mice calcitonin gene-related peptide (CGRP) immunoreactivity in the dorsal horn is dramatically reduced at both 3 and 28 days after rhizotomy. NGF transgenic and NGF/p75(-/-) mice also display reduced CGRP immunoreactivity 3 days after rhizotomy, but by postsurgical day 28 significant increases in the density of CGRP-positive axons are observed in the injured dorsal horns of these mice. Interestingly, NGF/p75(-/-) mice displayed significantly more new axonal growth when compared to NGF transgenic mice expressing full-length p75NTR. Immunohistochemical and ultrastructural analyses revealed that this axonal growth is not the result of regeneration but rather injury-induced sprouting by intact DRG central processes into the lesion site. This collateral growth is restricted to deafferentated areas of the dorsal horn, and we therefore propose that this is an example of compensatory sprouting by NGF-sensitive axons in the spinal cord, a response that is enhanced in the absence of NGF binding to p75NTR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15846783     DOI: 10.1002/cne.20537

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  9 in total

1.  Nerve growth factor promoter activity revealed in mice expressing enhanced green fluorescent protein.

Authors:  Michael D Kawaja; Laura J Smithson; Janet Elliott; Gina Trinh; Anne-Marie Crotty; Bernadeta Michalski; Margaret Fahnestock
Journal:  J Comp Neurol       Date:  2011-09-01       Impact factor: 3.215

2.  Neurotrophin selectivity in organizing topographic regeneration of nociceptive afferents.

Authors:  Lakshmi Kelamangalath; Xiaoqing Tang; Kathleen Bezik; Noelle Sterling; Young-Jin Son; George M Smith
Journal:  Exp Neurol       Date:  2015-06-06       Impact factor: 5.330

3.  Role of p75NTR in female rat urinary bladder with cyclophosphamide-induced cystitis.

Authors:  Mary Beth Klinger; Margaret A Vizzard
Journal:  Am J Physiol Renal Physiol       Date:  2008-10-08

Review 4.  Actions of neurotrophic factors and their signaling pathways in neuronal survival and axonal regeneration.

Authors:  Qi Cui
Journal:  Mol Neurobiol       Date:  2006-04       Impact factor: 5.682

Review 5.  The p75 neurotrophin receptor: at the crossroad of neural repair and death.

Authors:  Rick B Meeker; Kimberly S Williams
Journal:  Neural Regen Res       Date:  2015-05       Impact factor: 5.135

6.  BNN27, a 17-Spiroepoxy Steroid Derivative, Interacts With and Activates p75 Neurotrophin Receptor, Rescuing Cerebellar Granule Neurons from Apoptosis.

Authors:  Iosif Pediaditakis; Alexandra Kourgiantaki; Kyriakos C Prousis; Constantinos Potamitis; Kleanthis P Xanthopoulos; Maria Zervou; Theodora Calogeropoulou; Ioannis Charalampopoulos; Achille Gravanis
Journal:  Front Pharmacol       Date:  2016-12-26       Impact factor: 5.810

Review 7.  Capacity of astrocytes to promote axon growth in the injured mammalian central nervous system.

Authors:  Matin Hemati-Gourabi; Tuoxin Cao; Megan K Romprey; Meifan Chen
Journal:  Front Neurosci       Date:  2022-09-20       Impact factor: 5.152

8.  Increased nerve growth factor signaling in sensory neurons of early diabetic rats is corrected by electroacupuncture.

Authors:  Stefania Lucia Nori; Maria Luisa Rocco; Fulvio Florenzano; Maria Teresa Ciotti; Luigi Aloe; Luigi Manni
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-21       Impact factor: 2.629

9.  An optimized dosing regimen of cimaglermin (neuregulin 1β3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in rats.

Authors:  Jennifer F Iaci; Tom J Parry; Zhihong Huang; Elias Pavlopoulos; Seth P Finklestein; Jingmei Ren; Anthony Caggiano
Journal:  J Neurosci Res       Date:  2015-12-11       Impact factor: 4.164

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.